Revelation Biosciences, Inc. (NASDAQ:REVBW) Short Interest Update

Revelation Biosciences, Inc. (NASDAQ:REVBW) saw a large decrease in short interest in the month of April. As of April 15th, there was short interest totalling 1,300 shares, a decrease of 23.5% from the March 31st total of 1,700 shares. Based on an average daily volume of 78,500 shares, the days-to-cover ratio is presently 0.0 days.

Revelation Biosciences Stock Performance

NASDAQ REVBW remained flat at $0.01 during trading hours on Friday. The company had a trading volume of 9,705 shares, compared to its average volume of 75,348. Revelation Biosciences has a 12 month low of $0.01 and a 12 month high of $0.03. The firm has a fifty day moving average price of $0.02 and a 200-day moving average price of $0.01.

About Revelation Biosciences

Revelation Biosciences, Inc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease.